-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Virpax Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2020 to 2023.
- Virpax Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$1.92M, a 68.5% increase year-over-year.
- Virpax Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$13.4M, a 5.24% increase year-over-year.
- Virpax Pharmaceuticals, Inc. annual Operating Income (Loss) for 2023 was -$15.7M, a 28.2% increase from 2022.
- Virpax Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$21.8M, a 81.7% decline from 2021.
- Virpax Pharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was -$12M, a 187% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)